# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-22-000042
Filing Date
2022-05-11
Accepted
2022-05-11 16:06:20
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CIDARA THERAPEUTICS, INC. FORM 10-Q | cdtx-20220331.htm iXBRL | 10-Q | 1271253
2 | CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3112022-03.htm | EX-31.1 | 9946
3 | CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3122022-03.htm | EX-31.2 | 9922
4 | CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3212022-03.htm | EX-32.1 | 7450
5 | CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3222022-03.htm | EX-32.2 | 7485
| Complete submission text file | 0001610618-22-000042.txt |  | 5523439

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cdtx-20220331.xsd | EX-101.SCH | 37418
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cdtx-20220331_cal.xml | EX-101.CAL | 45385
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cdtx-20220331_def.xml | EX-101.DEF | 225475
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cdtx-20220331_lab.xml | EX-101.LAB | 504158
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cdtx-20220331_pre.xml | EX-101.PRE | 330496
53 | EXTRACTED XBRL INSTANCE DOCUMENT | cdtx-20220331_htm.xml | XML | 743098

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 22913701
SIC: 2836 Biological Products, (No Diagnostic Substances)